Dr. Joseph Burkhardt, orthopedic surgeon and physician partner at Brookside Surgery Center is participating in a 10 year follow-up trial of the ConforMISUNI G2 knee resurfacing device, an FDA cleared implant for patients with osteoarthritic damage in a single compartment of the knee. Unlike traditional total knee replacement which replaces the entire joint, the ConforMIS partial knee resurfacing device allows for the targeted and minimally invasive treatment of just the diseased area of the knee in properly indicated patients.
Click on link below to read entire article.